Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - disodium pamidronate 3 mg/ml - eq. pamidronic acid 2,527 mg/ml - concentrate for solution for infusion - 3 mg/ml - pamidronate disodium 3 mg/ml - pamidronic acid

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - disodium pamidronate 3 mg/ml - eq. pamidronic acid 2,527 mg/ml - concentrate for solution for infusion - 3 mg/ml - pamidronate disodium 3 mg/ml - pamidronic acid

Canada - English - Health Canada

pharmascience inc - pamidronate disodium - powder for solution - 30mg - pamidronate disodium 30mg - bone resorption inhibitors

Canada - English - Health Canada

pharmascience inc - pamidronate disodium - powder for solution - 90mg - pamidronate disodium 90mg - bone resorption inhibitors

Canada - English - Health Canada

pharmascience inc - pamidronate disodium - powder for solution - 60mg - pamidronate disodium 60mg - bone resorption inhibitors

Canada - English - Health Canada

pharmascience inc - pamidronate disodium - powder for solution - 15mg - pamidronate disodium 15mg - bone resorption inhibitors

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - disodium pamidronate 3 mg/ml (from the pentahydrate) - solution for injection - 30 mg/10ml - active: disodium pamidronate 3 mg/ml (from the pentahydrate) excipient: mannitol phosphoric acid water for injection - treatment of conditions associated with increased osteoclast activity: predominantly lytic bone metastasis and multiple myeloma.

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - disodium pamidronate 6 mg/ml (from the pentahydrate) - solution for injection - 60 mg/10ml - active: disodium pamidronate 6 mg/ml (from the pentahydrate) excipient: mannitol phosphoric acid water for injection - treatment of conditions associated with increased osteoclast activity: predominantly lytic bone metastasis and multiple myeloma.

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - disodium pamidronate 9 mg/ml (from the pentahydrate) - solution for injection - 90 mg/10ml - active: disodium pamidronate 9 mg/ml (from the pentahydrate) excipient: mannitol phosphoric acid water for injection - treatment of conditions associated with increased osteoclast activity: predominantly lytic bone metastasis and multiple myeloma.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pamidronate disodium, quantity: 3 mg/ml - injection, concentrated - excipient ingredients: mannitol; sodium hydroxide; phosphoric acid; water for injections - treatment of conditions associated with increased osteoclast activity: ? predominantly lytic bone metastases from breast cancer and advanced multiple myeloma. ? acute management of tumour induced hypercalcaemia (hypercalcaemia of malignancy). ? treatment of symptomatic paget?s disease of bone.